Medicinal concentrate of arbovirus specific immunoglobulins and F(ab)'2 and/or Fab fragments

The invention concerns a new medicinal product for the treatment of arboviruses, i.e.. a concentrate of immunoglobulins and F(ab)′2 and/or Fab fragments specific to said arbovirus as well as its process of preparation.

Saved in:
Bibliographic Details
Main Author Schmitthaeusler, Roland
Format Patent
LanguageEnglish
Published 10.08.2010
Online AccessGet full text

Cover

Loading…
Abstract The invention concerns a new medicinal product for the treatment of arboviruses, i.e.. a concentrate of immunoglobulins and F(ab)′2 and/or Fab fragments specific to said arbovirus as well as its process of preparation.
AbstractList The invention concerns a new medicinal product for the treatment of arboviruses, i.e.. a concentrate of immunoglobulins and F(ab)′2 and/or Fab fragments specific to said arbovirus as well as its process of preparation.
Author Schmitthaeusler, Roland
Author_xml – sequence: 1
  givenname: Roland
  surname: Schmitthaeusler
  fullname: Schmitthaeusler, Roland
BookMark eNqNjTsOwjAQBV1Awe8O2wEFggQhHwAR0dBRIqG1Y1srObuRHXN-EokDUM0rRvOWasbCbqFeD9eSJcYIVtg6HhIODsQDJiMfSiVD7p0lTxao6wpLiGJKJM6A3EKzQ7Pf1tM-SoIGDfiEoRtLea3mHmN2mx9XCprb83o_lNyPL6PxDgknnLTWla4v5z-UL2ANPag
ContentType Patent
CorporateAuthor Laboratoire Fancais du Fractionnement et des Biotechnologies
CorporateAuthor_xml – name: Laboratoire Fancais du Fractionnement et des Biotechnologies
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 07771725
GroupedDBID EFH
ID FETCH-uspatents_grants_077717253
IEDL.DBID EFH
IngestDate Sun Mar 05 22:34:03 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_077717253
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7771725
ParticipantIDs uspatents_grants_07771725
PatentNumber 7771725
PublicationCentury 2000
PublicationDate 20100810
PublicationDateYYYYMMDD 2010-08-10
PublicationDate_xml – month: 08
  year: 2010
  text: 20100810
  day: 10
PublicationDecade 2010
PublicationYear 2010
References (1385886) 20021100
Edelman R. et al., "Phase II safety and immunogenecity study of live chikungunya virus vaccine," Jun. 2000, Am. J. Trop. Med. Hyg., 62:681-5.
Kreil et al. Journal of Virology 71: 2921-2927 (1997).
Van Furth et al. The Journal of Infectious Diseases 149:511-517 (1984).
Erlich et al. Antimicrobial Agents and Chemotherapy 31: 1006-1009 (1987).
Ohara et al., "Prophylactic Efficacy of mmune erum Globulin against Hepatitis A," Jpn J. Exp. Med. 1986, 56(5):229-33.
Dreffier, et al., "Immunoprophylaxie des infections respiratoires," Medicine/Sciences 2004, vol. 20, pp. 999-1003.
Oncley et al., "The Separation of the Antibodies, Isoagglutinins, Prothrmbin, Plasminogen and B1-Lipoprotein into Subfractions of Human Plasma," 1949 J. Am. Chem. Soc. 71:541.
Steele et al. Journal of Clinical Microbiology 27:640-643 (1989).
Pialoux et al., "Chikungunya virus invection: review through an epidemic," Medecine et maladies infectieuses 36 (2006) pp. 253-263.
Boere et al. Journal of Virology 54:546-551 (1985).
A. Hamdan et al., "Possible benefit of Intravenous Immunoglobulin Therapy in Lung Transplant Recipient with West Nile Virus Encephalitis" Transplant Infectious Diseases, vol. 4, No. 3, Sep. 2002, pp. 160-162.
Cruse et al. "Illustrated Dictionary of Immunology." CRC press, Boca Raton, FL, 1995, p. 107.
Kunishige M, et al., "Preferential gray matter involvement in dengue myelitis," Neurology, Nov. 2004, vol. 63, No. 10, pp. 1980-1981.
Gaidamovitch et al. 1973 (Database EMBASE).
Ben-Nathan et al. The Journal of Infectious Diseases 188:5-12 (2003).
Shimoni et al. Emerging Infectious Diseases 7(4):759 (2001).
Chamberlain et al. (2005/0182080) 20050800
Thullier et al (Journal of Biotechnology 69:183-190, 1999).
Van de Water et al., "Rapid in vitro micro-cytotoxicity tests for the detection and quantitation of neutralizing antibodies to both viruses and toxins," Journal of Immunological methods 166(1993): 157-164.
Igarashi et al. (Passive immunization of mice with rabbit antisera against Chikungunya virus and its components, Biken Journal, 1971, vol. 14, pp. 353-355.
Bayry Jagadeesh et al., "Intravenous immunoglobulin for infectious diseases: tailor-made or universal?" The Journal of Infectious Diseases, Nov. 15, 2003, vol. 188, No. 10, p. 1610.
Briolant et al., "In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of enterferon-α and ribavirin combination," 2004.
Giovarelli et al. "Effect of Anti-u-Chain Specific Immunosuppression on Chikungunya Virus Encephalitis of Mice," Infection and Immunity, vol. 16, No. 3, Jun. 1977, pp. 849-852.
Steinbuch M., "The isolation of IgG From Mammalian Sera with the Aid of Caprylic Actid," Archiv. Biochem. Biophys., 134:279-284 (1969).
(WO2004091656) 20041000
Conrad Me et al., "Prevention of Endemic Icteric Viral Hepatitis by Administration of Immune Serum Gamma Globulin," J. Infect. Dis. 1987, 156(1):56-63.
Pastorino et al., "Epidemic Resurgence of Chikungunya Virus in Democratic Republic of the Congo"Journal of Medical Virology, 2004, vol. 74, pp. 277-282.
Agrawal et al. The Journal of Infectious Diseases 188:1-4 (2003).
References_xml – year: 20050800
  ident: 2005/0182080
  contributor:
    fullname: Chamberlain et al.
– year: 20041000
  ident: WO2004091656
– year: 20021100
  ident: 1385886
Score 2.7817328
Snippet The invention concerns a new medicinal product for the treatment of arboviruses, i.e.. a concentrate of immunoglobulins and F(ab)′2 and/or Fab fragments...
SourceID uspatents
SourceType Open Access Repository
Title Medicinal concentrate of arbovirus specific immunoglobulins and F(ab)'2 and/or Fab fragments
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7771725
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfVxNSwMxEB3aIqgnRcX6RQ6Ceojd7lfas3RZhEoPCj0IZbJJilB3S3YX_76ZrBQvegsJDENCZvLIew_gVqhYTWMjeRRpw2OBKcexTrnS0jg8EQrpFd7zlzR_i5-XybIH-U4L8-muEd-6XOrHtt42lSdXuvLeHTzvzJ_JI7Ak94GvclOhWigzEsIBkzDpQ38SELVvluWHsO9CuCdb2dS_mkZ2BHsLP3sMPV2ewPu8-8bGDStIK1h6X1hWGYZWOlxv25qR7pG4O-yDZBsVuXUQU7xmDu-z7B7lw11I41FlWYaSGYtrr1E7BZbNXp9yvktltbZEcVkFPylHZzBwUF-fAyuiscYkwRDVJJ5ggLIIhStAMp2qpIiCIQz_DHPxz9olHHS_3mTlegWDxrb62jXTRt74nfoGtOqB3w
link.rule.ids 230,309,783,805,888,64367
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfVxLSwMxEB5qFR8nRcX6zEFQD7HtPtuzGtZHyx4UehCWySZbhLpb9oF_30lWihe9hQSGISEz-cj3fQCXofLU2Mskd12dcS_EgONQB1xpmRGecEJpFd6TaRC9eU8zf9aBaKWF-aRrxJeUS3XbVMu6sORKKu_twfPW_Nl4BObGfeArXxSoYpX1w5CAieOvwTr12MBCMhHtwBYFoUdbXle_2obYhY3Yzu5BR-f78D5pP7JxwVKjFsytMywrMoalJGRfNhUzykfD3mEfRrhRGL8OwxWvGCF-Jq5R3lw5ZtwvSiZQsqzEuVWpHQATD693EV-lksxLQ3JJBj9Ju4fQJbCvj4Cl7lCj76ODauSNcIAydUIqQTIYKz91Bz3o_Rnm-J-1C9iM70Xy8jh9PoHt9gvc-LqeQrcuG31GnbWW53bTvgE8MITc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Medicinal+concentrate+of+arbovirus+specific+immunoglobulins+and+F%28ab%29%272+and%2For+Fab+fragments&rft.inventor=Schmitthaeusler%2C+Roland&rft.number=7771725&rft.date=2010-08-10&rft.externalDBID=n%2Fa&rft.externalDocID=07771725